Adenocarcinomas, apocrine C44.L43

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 02.03.2022

Dieser Artikel auf Deutsch

This section has been translated automatically.

This section has been translated automatically.

  • Under the term "apocrine adenocarcinomas" malignant tumors can be grouped, which were previously classified under the following names: Hidradenocarcinoma
  • Hidroadenocarcinoma papilliferum
  • basal cell carcinoma with apocrine differentiation
  • ductal carcinoma
  • tubular carcinoma
  • mucinous carcinoma
  • syringomatous carcinoma
  • Syringocytadenocarcinoma papilliferum.

Delineable entities include adnexal carcinoma, microcystic and extramammary Paget's disease.

This section has been translated automatically.

Axilla, anogenital region, more rarely breast, nipple, finger or capillitium.

Clinical features
This section has been translated automatically.

Mostly solitary, clinically not very distinct lump with a diameter of 2-8 cm.

This section has been translated automatically.

All adnexal carcinomas show the signs of malignancy such as asymmetry, blurred boundaries, invasive growth with destruction of local structures. A standard for the grading of adnexal carcinomas has not yet been developed. Remarkable is a variability in the extent of the cytological atypia. The tumor cells show positivity for cytokeratin, GCDFP-15, rarely for S100. They are CEA-negative.

This section has been translated automatically.

Undifferentiated carcinomas have a poor prognosis; tendency to metastasize to the regional lymph nodes.

This section has been translated automatically.

Malignant adnexal tumors of the skin with tubular or ductal differentiation are relatively rare. The individual observations which inevitably result from this have led to a widespread confusion regarding their diagnosis, classification and therapy. Adnexal carcinomas can develop de novo, but also in pre-existing benign tumours and hamartomas of the skin appendages. The classification of de novo developed undifferentiated adnexal carcinomas is often difficult. For example, the adenocarcinomas developing from a spiradenoma or a cylindrome usually lack any differentiation so that they could only be classified as poorly differentiated adenocarcinomas without the benign initial tumor. Their classification as an "eccrine adnexal carcinoma" is then not possible.

This section has been translated automatically.

  1. Kaddu S et al (2003) Adnexal tumors with apocrine differentiation. In: Kerl H et al (eds.) Dermatohistology. Springer, Berlin Heidelberg New York, S. 686-696
  2. McCalmont TH (2003) Adnexal neoplasms. In: JL Bologna et al (ed.) Dermatology. Mosby, London New York Toronto, S. 1733-1755


Please ask your physician for a reliable diagnosis. This website is only meant as a reference.


Last updated on: 02.03.2022